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The T-box gene tbx5 is expressed in the developing heart, forelimb, eye, and liver in vertebrate embryos during critical
tages of morphogenesis and patterning. In humans, mutations in the TBX5 gene have been associated with Holt–Oram
yndrome, which is characterized by developmental anomalies in the heart and forelimbs. In chicken and mouse embryos,
bx5 expression is initiated at the earliest stages of heart formation throughout the heart primordia and is colocalized with
ther cardiac transcription factors such as nkx-2.5 and GATA4. As the heart differentiates, tbx5 expression is restricted to
he posterior sinoatrial segments of the heart, consistent with the timing of atrial chamber determination. The correlation
etween tbx5 expression and atrial lineage determination was examined in retinoic acid (RA)-treated chicken embryos. tbx5
xpression is maintained throughout the hearts of RA-treated embryos under conditions that also expand atrial-specific gene
xpression. The downstream effects of persistent tbx5 expression in the ventricles were examined directly in transgenic
mice. Embryos that express tbx5 driven by a b-myosin heavy chain promoter throughout the primitive heart tube were
generated. Loss of ventricular-specific gene expression and retardation of ventricular chamber morphogenesis were observed
in these embryos. These studies provide direct evidence for an essential role for tbx5 in early heart morphogenesis and
hamber-specific gene expression. © 2000 Academic Press
Key Words: Tbx5; heart morphogenesis; cardiomyocyte lineage diversification; transgenic mice; retinoic acid.eINTRODUCTION
Tbx5 is a member of the T-box family of transcription
factors involved in multiple developmental processes in
vertebrate embryos. Mutation of the TBX5 gene in humans
has been associated with Holt–Oram syndrome (OMIM
142900), which is characterized by congenital heart and
limb defects (Basson et al., 1997; Li et al., 1997). The
developmental defects observed in Holt–Oram syndrome
are consistent with the localized pattern of tbx5 expression
in the developing hearts and limbs of chick, mouse, and
human embryos (Chapman et al., 1996; Li et al., 1997;
Bruneau et al., 1999). tbx5 is expressed in the anterior limb
bud and has been implicated in anterior vs posterior limb
specification (Takeuchi et al., 1999; Rodriguez-Esteban et
al., 1999). In the developing heart, tbx5 has a dynamic
restricted pattern of expression consistent with cardiac
anomalies associated with Holt–Oram syndrome (Bruneau
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All rights of reproduction in any form reserved.t al., 1999). Early in cardiac development, tbx5 expression
is restricted to the posterior segments of the primitive heart
tube, which is suggestive of a role in atrial lineage develop-
ment. However, specific functions of tbx5 in early heart
chamber formation have not been identified.
Early heart development in vertebrates is characterized
by the fusion of bilaterally placed heart primordia into a
primitive heart tube. Distinct anterior and posterior car-
diomyogenic lineages are apparent when the heart differen-
tiates (Yutzey and Bader, 1995). In the developing chick, an
atrial myosin heavy chain (AMHC1) is expressed in the
posterior atrial progenitors but not in the anterior ventricu-
logenic segments of the forming heart (Yutzey et al., 1994,
1995). In zebrafish embryos, atrial and ventricular precur-
sors are distinct prior to heart tube formation (Stainier and
Fishman, 1992). In mice, myosin light chain 2v (mlc2v)
expression is restricted to the anterior primitive heart tube
from the earliest stages of heart formation (O’Brien et al.,
1993). In addition, there is increasing evidence for early
complex patterning of the primitive heart tube from trans-
genic analyses of cardiac regulatory elements linked to
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170 Liberatore, Searcy-Schrick, and Yutzeyreporter genes in mice (Ross et al., 1996; He and Burch,
1997; Searcy et al., 1998; Lien et al., 1999; Reecy et al.,
999; Tanaka et al., 1999; Kuo et al., 1999; Xavier-Neto et
l., 1999). The molecular regulatory mechanisms that es-
ablish unique transcriptional programs in different regions
f the primitive heart are not well characterized. Genetic
inks between positionally restricted transcription factors
nd specific target genes have not been established.
Retinoids have been associated with the establishment of
ositionally restricted cardiomyogenic lineages in mouse,
hicken, and zebrafish embryos (Stainier and Fishman,
992; Yutzey et al., 1994; Xavier-Neto et al., 1999). Retinoic
acid (RA) treatment of chicken embryos in culture produces
an expansion of AMHC1 expression into the anterior seg-
ments of the heart (Yutzey et al., 1994, 1995). The anterior
ventricular lineage appears to be determined at the time of
differentiation since RA treatment of differentiated anterior
heart cells does not activate posterior gene expression
patterns (Yutzey et al., 1995). A posterior heart-specific
egulatory element for the quail homologue of AMHC1 was
dentified using transgenic analyses in mice (Xavier-Neto et
l., 1999). Gene expression from this element is activated
pecifically in the posterior sinoatrial region of the mouse
eart beginning at E8.25. Its expression is expanded into the
nterior heart tube in mice treated with RA at the early
tages of heart formation. Thus the anteroposterior pattern-
ng of the primitive heart likely involves localization of
etinoids or retinoid sensitivity (Moss et al., 1998; Xavier-
eto et al., 1999, 2000; Niederreither et al., 1999).
The function of tbx5 in early heart chamber development
was examined in chicken and mouse embryos. tbx5 is
initially expressed throughout the cardiogenic region and is
subsequently restricted to the sinoatrial segments of the
heart in chicken and mouse embryos. Treatment of chicken
and mouse embryos with retinoic acid has been demon-
strated to anteriorize atrial-specific gene expression (Yutzey
et al., 1994; Xavier-Neto et al., 1999). Similarly, tbx5
expression in the primitive heart is expanded in retinoic
acid-treated chicken embryos. Transgenic mouse embryos
that express tbx5 from a b-myosin heavy chain promoter
ere generated. Persistence of tbx5 expression in the devel-
oping ventricles of these embryos results in loss of
ventricular-specific gene expression and aberrant ventricu-
lar morphogenesis. These studies provide direct evidence
for a role for tbx5 in the early stages of atrial vs ventricular
lineage determination and chamber development.
MATERIALS AND METHODS
Isolation of mouse and chicken tbx5 cDNAs. A partial mouse
tbx5 cDNA sequence (obtained from Dr. V. Papaioannou) was used
o isolate the full-length tbx5 cDNA from a mouse embryonic day
0 (E10) heart cDNA library (obtained from Dr. J. Molkentin).
ybridization conditions were 53 SSPE, 53 Denhardt’s, 0.1 mg/ml
enatured herring testis DNA, 0.2% SDS at 42°C overnight.
ybridized filters were washed twice at room temperature in 23
SC/0.2% SDS and twice at 60°C in 0.23 SSC/0.2% SDS. Three
Copyright © 2000 by Academic Press. All rightDNA clones were isolated. The longest clone is 4.8 kb and
equence analysis confirms that it contains the entire reported
bx5 coding sequence (Bruneau et al., 1999).
An incomplete chicken tbx5 sequence was isolated after RT-
PCR amplification of stage 12–14 chicken embryo heart RNA.
Oligonucleotide primers for PCR were used to amplify nucleotides
from 1648 to 11361 of the reported chicken tbx5 sequence (Isaac
t al., 1998) (GenBank Accession No. AF033671). PCR conditions
ere 30 cycles of 1 min at 94°C, 1.5 min at 50°C, 3 min at 72°C.
he amplified sequence was inserted into a pBluescript T-vector
Marchuk et al., 1991) and its identity was confirmed by sequenc-
ng.
In situ hybridization. Staged mouse embryos were obtained
fter timed matings of FVBN mice with the morning of the
opulation plug being E0.5. Chicken embryos were isolated ex ovo
t E1–3 and staged according to Hamburger and Hamilton (1951).
mbryos were fixed overnight in 4% paraformaldehyde/PBS. In situ
ybridizations were performed as described by Wilkinson (1993)
ith previously described modifications (Searcy et al., 1998; Ehr-
an and Yutzey, 1999). In some cases, hybridized embryos were
nfiltrated with sucrose, frozen, and sectioned at 10–15 mm in OCT
edium (Searcy et al., 1998). Digoxigenin-labeled mouse tbx5 and
bx4 probes were synthesized from templates obtained from Dr. V.
apaioannou (Chapman et al., 1996). The mouse nkx-2.5, mlc1a,
nd mlc2v RNA probes and chicken AMHC1, GATA4, and nkx-2.5
NA probes were as previously described (Lyons et al., 1990;
utzey et al., 1994; Searcy et al., 1998; Schultheiss et al., 1995;
Molkentin et al., 1997; Kostetskii et al., 1999). The chicken tbx5
RNA probe was synthesized with T7 polymerase from a pBlue-
script template cut with XbaI. In all cases for both chicken and
mouse embryos, in situ hybridizations of control and experimental
embryos were conducted in parallel and NBT/BCIP color reactions
were stopped concurrently.
Chicken embryo cultures. Fertilized White Leghorn chicken
eggs were obtained from Spafas Farms (Roanoke, IL) and incubated
in high humidity at 38°C. Embryos were removed from the egg on
paper rings after 23–28 h of incubation and placed in culture
(Yutzey et al., 1994). Embryos were initially rinsed in PBS and
placed on thin albumin sandwiched between two rings. Culture
medium consisting of M199 (Sigma) plus penicillin–streptomycin
(Gibco BRL) was added and embryos were transferred to an incu-
bator at 37°C with 5% CO2. Retinoic acid-treated embryos were
exposed to 5 3 1026 M RA in 0.5% methanol and M199 culture
medium. Control embryos were cultured in M199 with 0.5%
methanol. Embryos were cultured overnight (15–24 h) and pro-
cessed for in situ hybridization or dissected for RNA isolation.
Generation of transgenic mouse embryos. The mouse tbx5
oding sequence (1555 bp) with approximately 1375 bp 59 and 715
p 39 untranslated sequence is contained between HindIII and
coRI restriction enzyme sites. The b-myosin heavy chain pro-
moter was obtained from Drs. M. Colbert and J. Robbins for
activation of gene expression throughout the primitive heart of
transgenic mice (Colbert et al., 1997). The mouse tbx5 coding
sequence was inserted into the SpeI site between the mouse
b-myosin heavy chain sequence and the SV40 small t intron and
polyadenylation sites. The b-myosin heavy chain promoter and
tbx5 coding sequence were released from the pGem9Z plasmid
after incubation with SfiI and NotI. The linear DNA was purified
and used to generate transgenic mice using standard techniques
(Searcy et al., 1998). In order to circumvent embryonic lethality
associated with transgene expression, embryos developing directly
from injected blastocysts in the F0 generation were examined.
s of reproduction in any form reserved.
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171Tbx5 and Heart Chamber SpecificationEmbryos were isolated 10 or 11 days after pronuclear microinjec-
tion and compared to control nontransgenic littermates. Trans-
genic embryos were identified after PCR genotyping with the 59
oligonucleotide primer directed against the b-myosin heavy chain
romoter (59-GAGTTCCCCAAGTGAATGAAA-39) and the 39
rimer directed against the mouse tbx5 coding sequence (59-
CAGACATTCAGTGGACT-39). Embryos were fixed overnight
n 4% paraformaldehyde in PBS for histology or in situ hybridiza-
ion.
RESULTS
Early cardiac gene expression of tbx5 is conserved in
chicken and mouse embryos. The expression of tbx5 was
examined in chicken and mouse embryos as an indicator of
possible tbx5 function in the critical early stages of heart
differentiation and patterning. In the developing chicken
embryo, tbx5 is expressed in the cardiogenic mesoderm at
stage 8 (Fig. 1A) and weak tbx5 expression was detected as
early as stage 7 (data not shown). nkx-2.5 is one of the
earliest cardiogenic markers and its expression defines the
heart-forming region in stage 5–8 chicken embryos (Schul-
theiss et al., 1995; Ehrman and Yutzey, 1999). tbx5 and
kx-2.5 expressions are coincident throughout the meso-
ermal cell layer at stage 8 (Figs. 1A and 1E). tbx5 expres-
sion is unique in that it is confined to the mesoderm,
whereas nkx-2.5 is expressed in the endodermal and ecto-
dermal layers of the headfold region (Schultheiss et al.,
1995, and data not shown). Thus tbx5 and nkx-2.5 expres-
sion domains are not completely coincident but both are
expressed throughout the cardiogenic mesoderm prior to
the initiation of cardiomyogenic differentiation in the
chick.
As the heart differentiates, tbx5 expression becomes
localized within the primitive heart tube. tbx5 expression
was compared with AMHC1 expression, which is restricted
to the posterior atriogenic segments of the primitive heart.
In the straight heart tube (stage 10), tbx5 expression extends
anterior to AMHC1 expression (Figs. 1B and 1F). As the
heart begins to loop, tbx5 expression becomes progressively
restricted to the posterior primitive heart tube in a domain
similar to that of AMHC1 expression in the heart at stage
14 (Figs. 1D and 1H). Additional reported domains of tbx5
expression, including the eye, pharyngeal arches, and ante-
rior limb bud, also were observed in stage 14 embryos (Isaac
et al., 1998; Gibson-Brown et al., 1998; Ohuchi et al., 1998).
In mouse embryos, a similar dynamic pattern of tbx5
expression was observed. tbx5 and nkx-2.5 are colocalized
throughout the anterior lateral heart-forming region at
E7.25 (Figs. 2A and 2E) and in the cardiac crescent at E7.5
(Figs. 2B and 2F). As the heart tube differentiates and fuses,
tbx5 expression becomes progressively more restricted to
the posterior sinoatrial segments of the primitive heart tube
(Figs. 2C and 2D). Expression of tbx5 is restricted to the
cardiogenic mesoderm (Fig. 2G), unlike nkx-2.5, which is
expressed in all three cell layers. In the developing limbs of
chickens and mice, tbx5 and tbx4 are restricted to anterior
Copyright © 2000 by Academic Press. All rightand posterior limb buds, respectively. The cardiac expres-
sion of tbx4 was examined to determine if tbx4 and tbx5 are
expressed differentially along the anteroposterior axis of the
heart. However, analysis of tbx4 expression in the develop-
ing heart did not reveal a similar complementary pattern of
tbx4 and tbx5 expression in atrial and ventricular segments.
tbx4 is not expressed in the heart-forming region or primi-
tive heart tube at E7–8. During these stages, tbx4 expres-
sion was detected only in the developing allantois (Fig. 2H).
Thus the combination of tbx4 and tbx5 expression does not
appear to demarcate different regions of the developing
heart, in contrast to their likely roles in anterior vs poste-
rior limb specification (Takeuchi et al., 1999; Rodriguez-
Esteban et al., 1999).
tbx5 gene expression is expanded in the hearts of reti-
noic acid-treated chicken embryos. Chicken embryos
treated with retinoic acid during heart formation exhibit
altered anteroposterior patterning of the developing heart
(Yutzey et al., 1994, 1995). Specifically, expression of
AMHC1, which is normally confined to the posterior heart
tube, is expanded into the anterior ventriculogenic regions
with retinoic acid treatment. The effect of added retinoids
on positionally restricted expression of tbx5 in the devel-
oping heart was examined. Chicken embryos were removed
from the egg at stages 7–8 and treated with either 5 3
1026M all trans-retinoic acid or vehicle (0.5% MeOH)
overnight in culture. During this time the heart primordia
fuse to form the primitive heart tube and the heart begins to
beat. In most cases, embryos treated with RA or control
vehicle formed primitive heart tubes. RA-treated embryos
and parallel control embryos were examined for expression
of tbx5, GATA4, or nkx-2.5. In comparable stage 11 em-
ryos developing in ovo, tbx5 and GATA4 are restricted to
the posterior sinoatrial segments of the heart, whereas
nkx-2.5 is expressed throughout the heart. GATA4 expres-
sion in the heart is sensitive to retinoid status in similarly
staged quail embryos and was included in the analysis as a
control for retinoid-responsive gene expression (Kostetskii
et al., 1999). Control embryos hybridized with tbx5 exhib-
ited normal expression restricted to the posterior sinoatrial
regions of the developing heart (Fig. 3A). With RA treat-
ment, the domain of tbx5 expression is expanded into the
anterior segments of the heart in 16/19 treated embryos
(Fig. 3D; Table 1). In contrast, restricted tbx5 expression
was observed in 17/17 control embryos. tbx5 expression
also is expanded in the lateral plate mesoderm posterior to
the heart. Histological analysis of embryo sections shows
that the expansion of tbx5 expression occurs in the myo-
cardial cell layer of the anterior heart (Figs. 4B and 4D).
However, tbx5 expression in the myocardium of control
embryos is restricted to posterior segments of the primitive
heart tube (Figs. 4A and 4C). Thus tbx5 expression, like
AMHC1 expression, is expanded anteriorly in the develop-
ing heart with RA treatment.
As the primitive heart tube forms, GATA4 expression,
like tbx5 expression, becomes restricted to the posterior
heart tube. GATA4 expression was examined in RA-treated
s of reproduction in any form reserved.
i
F
w
m
p
E
e
d
172 Liberatore, Searcy-Schrick, and YutzeyFIG. 1. tbx5 is expressed in the heart primordia and posterior primitive heart in developing chicken embryos. (A–D) Stage 8–14
(Hamburger and Hamilton) chicken embryos were hybridized with a tbx5 antisense RNA probe. (A) At stage 8, tbx5 is expressed throughout
the heart-forming region. (B–D) At stages 10, 12, and 14, respectively, tbx5 expression is restricted to the posterior atrial region of the
primitive heart. Later stage embryos also exhibit expression in the dorsal aspects of the developing eye, pharyngeal clefts, and forelimb bud
(arrowheads in D). (E) nkx-2.5 also is expressed in the heart-forming region at stage 8. (F–H) AMHC1 (atrial-specific myosin heavy chain)
s expressed in the posterior atrial region at stages 10, 12, and 14. Arrows in C, D, G, and H indicate the A-V junction.
IG. 2. tbx5 is expressed in the cardiac crescent and posterior primitive heart in developing mouse embryos. Early stage mouse embryos
ere hybridized with a tbx5 antisense RNA probe. (A) tbx5 is expressed in bilaterally placed heart primordia and cardiac crescent in the
ouse at embryonic day 7.25–7.5 (arrowheads). The expression of tbx5 in the cardiac crescent is colocalized with nkx2.5 expression (E, F)
rior to cardiomyogenic differentiation. (C, D) tbx5 expression is maintained in the posterior primitive heart tube of the mouse at E8.0 to
9.5. The presumptive A-V junction is indicated by arrows. (G) Histological analysis of sections of mouse E7.5 shows mesodermal
xpression in the forming heart (arrowheads). (H) Expression of tbx4 is limited to the allantois and shows no cardiac expression in early
evelopment.
Copyright © 2000 by Academic Press. All rights of reproduction in any form reserved.
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173Tbx5 and Heart Chamber Specificationembryos as evidence for a coordinated regulatory mecha-
nism controlling GATA4 and tbx5 expression during heart
formation. Increased GATA4 expression was observed in all
treated embryos. With RA treatment, expanded expression
of both tbx5 and GATA4 was observed in the primitive
heart tube and in the posterior lateral regions beyond the
heart-forming region (Figs. 3B and 3E; Table 1). In all cases,
GATA4 activation in the posterior lateral mesoderm was
more widespread than the expression domain of tbx5. In
contrast, no expanded expression was observed for nkx-2.5
in the posterior lateral mesoderm and normal expression is
maintained throughout the primitive heart tube (Figs. 3C
and 3F). However, increased nkx-2.5 expression was consis-
FIG. 3. Expression of cardiac transcription factors is expanded in r
from the egg on paper rings at stages 7–9 and placed in modified Ne
0.5% methanol. (D–F) RA-treated embryos were cultured in the ab
ere evaluated for tbx5 (A, D), GATA4 (B, E), or nkx-2.5 (C, F) expre
f tbx5 and GATA4 anteriorly in the heart is indicated by arrowhea
nd GATA4 (E) is indicated by arrows.tently observed in the underlying pharyngeal region of
Copyright © 2000 by Academic Press. All rightRA-treated embryos. Embryos treated prior to condensa-
tion of the heart primordia (stages 5– 6) also exhibited
increased expression of tbx5 and GATA4 in the lateral
plate mesoderm (data not shown). However, nkx-2.5
expression was reduced in these embryos, consistent
with previously reported inhibition of cardiogenesis in
embryos treated with RA early in heart formation (Drys-
dale et al., 1994; Searcy and Yutzey, 1998; Jiang et al.,
1999). Together these studies demonstrate that distinct
regulatory mechanisms control the expression of differ-
ent cardiac transcription factors within the primitive
heart. In addition, a retinoid-sensitive mechanism con-
trols the posterior localization of both GATA4 and tbx5
ic acid-treated chicken embryos. Chicken embryos were removed
lture. (A–C) Control embryos were exposed to M199 medium with
edium with 5 3 1025 M all trans-retinoic acid. Cultured embryos
by whole-mount in situ hybridization. (D, E) Expanded expression
xpanded expression in the posterior lateral mesoderm for tbx5 (D)etino
w cu
ove m
ssion
ds. Eexpression during early heart formation.
s of reproduction in any form reserved.
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174 Liberatore, Searcy-Schrick, and YutzeyVentricular development is inhibited by persistent ex-
pression of tbx5 throughout the developing heart of trans-
genic mouse embryos. Expansion of tbx5 expression in
the primitive chicken heart in response to RA treatment is
suggestive of a role for tbx5 in development of the posterior
venous segments of the primitive heart (Figs. 3 and 4).
However these experiments do not address the importance
of the posterior restriction of tbx5 expression on the devel-
oping heart directly. Transgenic mouse embryos were gen-
erated with cardiac-specific expression of tbx5 driven by a
mouse b-myosin heavy chain (b-MyHC) regulatory ele-
ment. This promoter activates gene expression throughout
the primitive heart tube beginning at E8 when the endoge-
nous tbx5 gene is normally downregulated in the develop-
ing ventricles (Colbert et al., 1997). The reduction of
endogenous tbx5 expression in the anterior heart coincides
with the determination of atrial and ventricular lineages
upon differentiation demonstrated in chicken embryos
(Satin et al., 1988; Yutzey et al., 1995). The temporal and
spatial restriction of transgenic b-MyHC-driven Tbx5 ex-
pression to the differentiating heart circumvents any effects
of altered Tbx5 function on other developmental processes.
These include anomalies in gastrulation, cardiac lineage
specification, vasculogenesis, or pharyngeal arch develop-
ment that could produce cardiac defects unrelated to heart
chamber formation in embryos with targeted mutation of
TABLE 1
Effects of Retinoic Acid Treatment on Transcription Factor Gene
Expression in Cultured Chicken Embryos
Expression
throughout
heart
Lateral plate mesoderm
expression beyond
somite 3
ontrol embryos
(0.5% MeOH)
nkx-2.5 11 (11) 0 (11)
tbx5 0 (17) 0 (17)
GATA4 2 (7) 2 (7)
A-treated embryos
(5 3 1026 M RA)
nkx-2.5 12 (12) 0 (12)
tbx5 16 (19) 13 (19)
GATA4 8 (11) 10 (11)
Note. The total number of embryos examined is in parentheses.
All embryos were treated beginning at stages 7–8. The number of
positive embryos for each parameter is not in parentheses. Embryos
were scored after in situ hybridization with indicated antisense
RNA probes. Treated and untreated embryos were analyzed in
parallel throughout the in situ hybridization procedure. Embryos
were classified as expressing “throughout the heart” based on
well-characterized morphological cardiac structures and parallel
nkx-2.5 expression. Posterior lateral mesoderm expression was
categorized based on the nearest somite medial to the posterior
limit of gene expression as detected by in situ hybridization.the tbx5 gene. Thus embryos generated with the b-MyHC–
Copyright © 2000 by Academic Press. All righttbx5 transgene were used to examine the effects of altered
Tbx5 function specifically on heart chamber development
at the time when atrial and ventricular lineages become
diversified.
The effects of persistent tbx5 expression on the ventricu-
logenic segments of the heart were examined in transgenic
mouse embryos. For these studies, a tbx5 cDNA encoding
the full-length protein was isolated from an E10 mouse
heart cDNA library. Sequence analysis indicates that the
isolated tbx5 sequence is 100% identical to the reported
mouse Tbx5 sequence at the amino acid level (Bruneau et
al., 1999). The Tbx5 coding sequence was linked to the
b-MyHC promoter for generation of transgenic mice. No
transgenic founder mice were obtained after initial injec-
tions, suggesting that expression of the transgene results in
embryonic lethality. Subsequent transgenic F0 embryos
ere isolated 10–11 days after pronuclear microinjection of
b-MyHC–tbx5 DNA. A total of 11 of 55 embryos examined
were identified as transgenic by PCR amplification of the
transgene. Eight of the transgenic embryos exhibited car-
diac developmental anomalies such as looping defects or
evidence of hemodynamic failure.
An example of a transgenic b-MyHC-tbx5 embryo with
its nontransgenic littermate isolated at E11.5 is shown in
Fig. 5. The transgenic embryo is at least a day behind the
nontransgenic embryo in development and exhibits abnor-
mal heart morphogenesis. An abnormally large amniotic
sac relative to the size of the embryo was an indicator of
generalized retardation of development. The transgenic
embryo has apparently normal head and pharyngeal arch
development relative to comparably staged nontransgenic
embryos isolated a day earlier. However, abnormal heart
morphogenesis was evident in retardation of heart looping
and absence of the A-V constriction. Indicators of hemody-
namic failure, including pooling of blood in the sinus
venosus and pericardial effusion, also were observed. Since
the transgenic tbx5 expression is targeted specifically to the
heart, dilation and ballooning of the heart that can occur as
an indirect effect of vascular defects were not observed
(Copp, 1995). The translucence and lack of beating of the
anterior heart tube are further evidence for poor ventricular
chamber development in the transgenic embryo. However,
smooth muscle a-actin, an early marker of cardiomyogenic
ifferentiation, was expressed throughout the heart (data
ot shown). Thus expression of the b-MyHC–tbx5 trans-
gene specifically affects the progression of ventricular de-
velopment and likely results in embryonic lethality at or
soon after E10.5.
Additional b-MyHC–tbx5 transgenic embryos were gen-
rated and analyzed for changes in ventricular gene expres-
ion and chamber morphogenesis. Ten transgenic embryos
ere isolated at E10.5, 7 of which appeared to have heart
ooping defects or abnormalities in early chamber morpho-
enesis. In situ hybridization with a tbx5 antisense probe
was used to detect expression of the transgene relative to
nontransgenic littermates. The endogenous tbx5 gene is
expressed in the atria and sinus venosus segments of the
s of reproduction in any form reserved.
cs
g
t
c
t
e
175Tbx5 and Heart Chamber Specificationheart and in the forelimbs (Fig. 6A). In contrast, the
b-MyHC–tbx5 transgene is expressed ectopically through-
out the heart and also in the somites (Fig. 6E). The three
apparently normal transgenic embryos did not have ectopic
expression of tbx5 detectable by in situ hybridization,
indicative of transcriptionally inactive transgenes. Expres-
sion of tbx5 in the ventricles did not affect cardiomyogenic
differentiation or generalized contractile protein gene ex-
pression throughout the heart since mlc1a expression was
normal in transgenic embryos (Fig. 6F, n 5 2). The effects of
persistent tbx5 expression on the ventricular-specific ex-
pression of mlc2v were examined as a specific indicator of
normal ventricular development in transgenic embryos. In
nontransgenic hearts, mlc2v expression is restricted to the
onotruncal and ventricular segments beginning at E8.0. In
b-MyHC–tbx5 transgenic embryos (n 5 2) mlc2v expres-
ion was obviously reduced relative to control nontrans-
enic littermates (Figs. 6G and 6H). Histological analysis of
b-MyHC transgenic embryos also demonstrates abnormal
ventricular development consistent with a specific loss in
mlc2v expression (Fig. 7). Reduced trabeculation of the
ventricles was apparent in all transgenic embryos exam-
ined. In some cases A-V cushion development also was
impaired. A-V cushion induction appeared to be inhibited
and the positioning of the cushions was abnormal. Taken
together these analyses suggest that persistence of tbx5
expression in the ventricles leads to a loss of ventricular
identity and a failure of the ventricles to progress in their
development.
DISCUSSION
The expression of tbx5 throughout the heart-forming
region prior to heart differentiation and posterior restriction
in the primitive heart tube is consistent with atriogenic
potential of cardiac myocytes during development. Prior to
differentiation, the anterior ventriculogenic region of the
heart-forming region has atriogenic potential if treated with
retinoic acid or transplanted into the developing atria (Satin
et al., 1988; Yutzey et al., 1995). This plasticity in ventric-
ular cell fate is lost after the ventricles have differentiated.
In chicken, mouse, and frog embryos, expression of tbx5
throughout the heart-forming region is consistent with the
plasticity of diversified cardiomyogenic lineages at this
time (Bruneau et al., 1999; Horb and Thomsen, 1999). tbx5
FIG. 4. tbx5 is expressed in the anterior myocardium of RA-treat
bx5 shown in Figs. 3A and 3D were sectioned for histological ana
xpress tbx5 (A), whereas normal tbx5 expression was observed in
observed in the myocardial layer of anterior and posterior segmen
FIG. 5. Embryonic development is retarded and hearts are abno
embryos were isolated 11 days after microinjection with a tbx5 c
embryo on the left is shown with a nontransgenic littermate (righ
pooling, and pericardial effusion. The arrowhead in (C) indicates a lack
Copyright © 2000 by Academic Press. All rightexpression is subsequently restricted to the posterior sino-
atrial region of the primitive heart tube when distinct atrial
and ventricular lineages become apparent. RA treatment of
chicken embryos during heart formation produces an ex-
pansion of tbx5 expression into the ventricular segments of
the heart similar to that observed for AMHC1 (Yutzey et
al., 1994, 1995). The function of Tbx5 specifically in early
heart chamber formation was examined in transgenic mice
that express tbx5 throughout the primitive heart from a
b-MyHC promoter. In these embryos, ventricular-specific
expression of mlc2v is reduced and ventricular trabecula-
tions fail to develop. The lack of appropriate early atrial-
specific markers in the mouse precludes a direct examina-
tion of atrial gene activation in the ventricles of b-MyHC–
bx5 embryos. However, the loss of ventricle-specific
haracteristics in b-MyHC–tbx5 transgenic mouse embryos
and RA responsiveness of tbx5 gene expression in chicken
embryos are indicative of a role for Tbx5 in the initial
diversification of atrial and ventricular chambers of the
heart.
The diversified phenotypes of distinct anterior and pos-
terior cardiomyogenic lineages in the tubular heart are
sensitive to retinoids in mouse and chicken embryos.
Anteriorization of AMHC1, tbx5, and GATA4 expression
beyond the sinoatrial segments of the heart occurs in
RA-treated chicken embryos (Yutzey et al., 1994). Similar
retinoid sensitivity has been observed for an atrial-specific
myosin heavy chain transgene in RA-treated mouse em-
bryos (Xavier-Neto et al., 1999). In addition GATA4/5/6
expression is sensitive to retinoid status in Xenopus and
avian embryos (Kostetskii et al., 1999; Jiang et al., 1999). A
potential mechanism mediating localized retinoid signaling
in vivo is the restricted expression of retinaldehyde
dehydrogenase-2 (RALDH-2), a limiting enzyme in RA
biosynthesis (Moss et al., 1998; Niederreither et al., 1999;
Xavier-Neto et al., 2000). In the primitive heart tube of
mouse and avian embryos, the expression of raldh-2 is
restricted to the posterior sinoatrial segments (Moss et al.,
1998; Xavier-Neto et al., 1999, 2000). Targeted disruption of
raldh-2 in mice results in defects in heart chamber devel-
opment (Niederreither et al., 1999). Homozygous raldh-2
mutant embryos were observed to have a single dilated
ventricular-like chamber and the atria were absent (Nied-
erreither et al., 1999). Together these studies suggest that
restricted RA biosynthesis in the posterior heart is critical
for atrial chamber development. With RA-treatment of
icken embryos. RA-treated and control embryos hybridized with
. Anterior segments of the heart of the untreated embryo did not
posterior heart (C). In the RA-treated embryo tbx5 expression was
the heart (B, D).
in b-MyHC–tbx5 transgenic mouse embryos. Transgenic mouse
g sequence driven by the b-MyHC promoter. (A) The transgenic
, C) The transgenic embryo heart shows abnormal looping, blooded ch
lysis
the
ts of
rmal
odin
t). (Bof constriction at the A-V junction.
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(l
177Tbx5 and Heart Chamber SpecificationFIG. 6. mlc2v expression is reduced in b-MyHC–tbx5 transgenic embryos. Nontransgenic (A–D) and transgenic littermates (E–H) were
hybridized with tbx5 (A, E), mlc1a (B, F), or mlc2v (C, D, G, H) antisense RNA probes. Ectopic expression of tbx5 was evident in the heart
large arrowhead) and somites (small arrows) of the transgenic embryo (E; n 5 3). mlc1a is expressed throughout the heart in transgenic
(n 5 2) and nontransgenic embryos (B, F). mlc2v expression (G, H) is reduced in transgenic embryos (n 5 2) relative to nontransgenic
ittermates (C, D). Abnormal heart looping also was apparent in the transgenic embryos (n 5 8).
Copyright © 2000 by Academic Press. All rights of reproduction in any form reserved.
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178 Liberatore, Searcy-Schrick, and Yutzeywhole embryos, RA exposure is delocalized in the heart and
the ventricles take on an atrial phenotype. Thus a retinoid-
related regulatory pathway is likely responsible for the
restriction of transcription factors such as tbx5 and GATA4
and contractile proteins such as AMHC1 to the posterior
sinoatrial segments of the primitive heart tube.
Retinoid treatment of avian embryos reveals distinct
regulatory mechanisms that control expression of transcrip-
tional regulators of early heart development. nkx-2.5, tbx5,
and GATA4 are coexpressed in the cardiogenic mesoderm
rior to heart differentiation (Schultheiss et al., 1995; Ko-
tetskii et al., 1999). In Xenopus embryos, conditional
xpression of the tbx5 T-box linked to an engrailed tran-
criptional repression domain results in loss of cardiac
tructures (Horb and Thomsen, 1999). Thus tbx5, like
kx-2.5 and GATA4/5/6, has a critical role in the earliest
tages of heart development. The regulatory relationships
mong these factors and their specific functions in early
eart development appear complex. Treatment of avian or
enopus embryos with RA prior to condensation of the
eart primordia results in a loss of nkx-2.5 expression and
nhibition of cardiomyogenic differentiation (Searcy and
utzey, 1998; Jiang et al., 1999). Under similar conditions,
ATA4/5/6 are upregulated in Xenopus embryos and tbx5
nd GATA4 are upregulated in chicken embryos (Jiang et
l., 1999). RA treatment of later stage chicken embryos does
ot affect nkx-2.5 expression but GATA4 and tbx5 are still
ncreased. Together these studies indicate that distinct
egulatory mechanisms control nkx-2.5 vs GATA4/5/6 and
bx5 expression. There is increasing evidence for cross-
egulation among early cardiac regulatory factors. In mice,
onsensus binding sites for GATA factors are important for
kx-2.5 expression and consensus binding sites for Nkx
roteins are important for GATA6 expression (Searcy et al.,
998; Lien et al., 1999; Molkentin et al., 2000; Davis et al.,
2000). In addition, dominant negative function of Tbx5EnR
in Xenopus embryos results in loss of nkx-2.5 expression
(Horb and Thomsen, 1999). Therefore Tbx5 is a component
of the reinforcing regulatory interactions that control car-
diac lineage determination and patterning.
The downstream targets of Tbx5 have not been reported.
Other T-box genes such as brachyury and VegT are involved
in mesoderm induction and tbx6 is required for paraxial
mesoderm lineage determination (Smith, 1997; Zhang et
al., 1998; Chapman and Papaioannou, 1998). Among the
direct targets of Brachyury during mesoderm induction in
Xenopus are eFGF and the homeobox gene Bix1 (Casey et
al., 1998; Tada et al., 1998). Thus T-box proteins appear to
play dual roles in growth and patterning at critical stages of
FIG. 7. Abnormal chamber development and reduced ventricul
mbryos shown in Fig. 6 were sectioned for analysis of chamber
evelopment are apparent in nontransgenic embryos hybridized w
entricles is apparent in transgenic embryos (C, D). Abnormally siz
everal of the transgenic embryos (D, and data not shown).
Copyright © 2000 by Academic Press. All rightembryogenesis. In the present study, overexpression of tbx5
in the developing ventricles of the heart in transgenic mice
results in loss of ventricular trabeculations and reduced
chamber-specific gene expression. Similarly, overexpres-
sion of tbx5 in developing chicken hindlimbs results in
rrested limb development and hypoplasia (Takeuchi et al.,
999; Rodriguez-Esteban et al., 1999). In addition, the
indlimbs take on forelimb characteristics with altered
MP, FGF, and Wnt expression patterns. Ectopic expression
f Tbx5 in the developing avian eye similarly affects both
ositionally restricted patterns of gene expression and
rowth (Koshiba-Takeuchi et al., 2000). While targets of
bx5 in the forelimbs, eye, and heart have not been identi-
ed, alteration of tbx5 expression in each system alters the
ize and patterning of the affected structure.
Several different mutations in the human TBX5 gene
ave been identified in individuals with Holt–Oram syn-
rome (Basson et al., 1997; Li et al., 1997). The diversity in
TBX5 mutations likely underlies the variability in pheno-
types of individuals with Holt–Oram syndrome (Basson et
al., 1999). Cardiac defects associated with Holt–Oram syn-
drome include atrial and ventricular septal defects, conduc-
tion system defects, hypoplastic left heart, trabecular de-
fects, and valve defects (Bruneau et al., 1999). These
nomalies are consistent with altered cell identity or pro-
iferation in regions of the heart where tbx5 is normally
xpressed. At the later stages of chamber morphogenesis
E13.5), tbx5 is expressed in the trabeculae but not the
ompact layer of the ventricular myocardium (Bruneau et
l., 1999). The failure of diversified ventricular myocardial
ayers to develop in b-MyHC–tbx5 transgenic embryos may
be directly related to unrestricted tbx5 expression within
the early ventricular myocardium. In addition, tbx5 also
appears to be important in establishing early patterns of
chamber-specific gene expression. The complexity of local-
ized tbx5 expression and repression at different stages of
heart development points to diverse critical roles in car-
diomyogenic lineage identity and heart chamber morpho-
genesis.
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